GTC
PCRX icon

Ghost Tree Capital’s Pacira BioSciences PCRX Stock Holding History

Ghost Tree Capital’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-250,000
Closed -$9.52M – 55
2019
Q3 		$9.52M Buy
+250,000
New +$9.98M 2.42% 17
2016
Q3 		– Sell
-120,000
Closed -$4.05M – 95
2016
Q2 		$4.05M Buy
+120,000
New +$5.9M 1.17% 36
2016
Q1 		– Sell
-30,000
Closed -$2.3M – 61
2015
Q4 		$2.3M Sell
30,000
-50,000
-63% -$2.83M 0.94% 37
2015
Q3 		$3.29M Buy
+80,000
New +$4.9M 1.48% 24

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return